PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Rare ectopic metastasis from clear cell renal cell carcinoma to the chest wall after 10 years: A case report.

Abstract Clear cell renal cell carcinoma (CCRCC) is an aggressive tumor associated with a high risk of metastasis and very low survival rate. In addition, it can cause extensive blood metastasis to the lungs, bones, and other organs. Chest wall metastatic tumors from primary CCRCC are rare.
PMID
Related Publications

Bilateral metastases of renal cell carcinoma to the ovaries--a case report.

Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.

Massive hemothorax secondary to metastatic renal carcinoma.

Occult Thyroid Follicular Carcinoma Diagnosed as Metastasis to the Chest Wall.

Large chest wall metastasis with no recognizable primary lesion.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29742714
OWN - NLM
STAT- MEDLINE
DCOM- 20180516
LR  - 20180516
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 19
DP  - 2018 May
TI  - Rare ectopic metastasis from clear cell renal cell carcinoma to the chest wall
      after 10 years: A case report.
PG  - e0687
LID - 10.1097/MD.0000000000010687 [doi]
AB  - RATIONALE: Clear cell renal cell carcinoma (CCRCC) is an aggressive tumor
      associated with a high risk of metastasis and very low survival rate. In
      addition, it can cause extensive blood metastasis to the lungs, bones, and other 
      organs. Chest wall metastatic tumors from primary CCRCC are rare. PATIENT
      CONCERNS: In this report, we present a case of metastatic chest wall tumor that
      originated from a CCRCC. DIAGNOSES: An 86-year-old man was diagnosed with chest
      wall tumor using chest computed tomography. After collecting tissues from the
      chest wall tumor via needle biopsy, the pathological examination was combined
      with positive immunoreaction of CD10, epithelial membrane antigen, and vimentin, 
      and the patient was diagnosed with metastatic CCRCC in the chest wall deposits.
      INTERVENTIONS: The patient received radiotherapy at 2.0 Gy per time for 25 times.
      OUTCOMES: Following 2 months of treatment, the chest wall tumor had shrunk by
      about one-third of its size. LESSONS: Our patient developed a metastatic chest
      wall tumor that originated from a CCRCC for which right nephrectomy had been
      performed 10 years previously. Although as per the literature, chest wall
      metastasis from CCRCC is very rare, it is important to consider tumor metastasis 
      after several years of treatment for precise diagnosis and proper treatment.
FAU - Jiang, Chunyang
AU  - Jiang C
AD  - Department of Thoracic Surgery, Tianjin Union Medical Center, Hongqiao District, 
      Tianjin.
FAU - Zhao, Shan
AU  - Zhao S
AD  - Department of Medical Oncology, The Second Hospital of Hebei Medical University, 
      Xinhua District, Shijiazhuang.
FAU - Yang, Bingjun
AU  - Yang B
AD  - Department of Thoracic Surgery, Tianjin Union Medical Center, Hongqiao District, 
      Tianjin.
FAU - Tang, Tao
AU  - Tang T
AD  - Department of Pathology.
FAU - Hou, Ruipeng
AU  - Hou R
AD  - Department of Urology Surgery, Tianjin Union Medical Center, Hongqiao District,
      Tianjin.
FAU - Liu, Xiaoqin
AU  - Liu X
AD  - Department of Nephrology, Hongqi Hospital, Mudanjiang Medical College, Aimin
      District, Mudanjiang, Heilongjiang, People's Republic of China.
FAU - Zhao, Hui
AU  - Zhao H
AD  - Department of Thoracic Surgery, Tianjin Union Medical Center, Hongqiao District, 
      Tianjin.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - AIM
SB  - IM
MH  - Aged, 80 and over
MH  - Carcinoma, Renal Cell/*pathology/surgery
MH  - Humans
MH  - Kidney Neoplasms/*pathology/surgery
MH  - Male
MH  - Nephrectomy
MH  - Thoracic Neoplasms/radiotherapy/*secondary
MH  - Thoracic Wall/*pathology
MH  - Time Factors
EDAT- 2018/05/10 06:00
MHDA- 2018/05/17 06:00
CRDT- 2018/05/10 06:00
PHST- 2018/05/10 06:00 [entrez]
PHST- 2018/05/10 06:00 [pubmed]
PHST- 2018/05/17 06:00 [medline]
AID - 10.1097/MD.0000000000010687 [doi]
AID - 00005792-201805110-00033 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 May;97(19):e0687. doi: 10.1097/MD.0000000000010687.